Post-operative Cognitive Function Following Pelvic Floor Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04554550 |
|
Recruitment Status :
Active, not recruiting
First Posted : September 18, 2020
Last Update Posted : February 9, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Pelvic Organ Prolapse |
| Study Type : | Observational |
| Actual Enrollment : | 30 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Post-operative Cognitive Function Following Pelvic Floor Surgery |
| Actual Study Start Date : | August 13, 2020 |
| Estimated Primary Completion Date : | February 28, 2022 |
| Estimated Study Completion Date : | March 31, 2022 |
- Change in episodic memory neurocognitive test scores [ Time Frame: 8 weeks ]Episodic memory will be assessed using the Scene Encoding/Recognition Test
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 60 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria: Women 60 years of age or older who are scheduled to undergo surgery for pelvic organ prolapse.
Exclusion Criteria:
- Women who have a known baseline diagnosis of cognitive dysfunction or central nervous disorder
- A Mini-Mental State Exam (MMSE) score of greater than 24
- Non-english speaking
- Any severe visual or auditory disorder
- Alcoholism or drug dependence
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04554550
| United States, Pennsylvania | |
| University of Pennsylvania | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Principal Investigator: | Uduak Andy, MD | University of Pennsylvania |
| Responsible Party: | Uduak Andy, Assistant Professor of Obstetrics and Gynecology, University of Pennsylvania |
| ClinicalTrials.gov Identifier: | NCT04554550 |
| Other Study ID Numbers: |
843178 |
| First Posted: | September 18, 2020 Key Record Dates |
| Last Update Posted: | February 9, 2022 |
| Last Verified: | February 2022 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Prolapse Pelvic Organ Prolapse Pathological Conditions, Anatomical |

